Document is current
Any future updates will be listed below
-
Authors
Bender, Andreas https://orcid.org/0000-0002-6683-7546
Thomas, Morgan C.
Scannell, Jack W. https://orcid.org/0000-0002-0480-4140
Shaywitz, David A. https://orcid.org/0009-0000-1734-510X
Ghiandoni, Gian Marco https://orcid.org/0000-0002-2592-2939
Greener, Joe G. https://orcid.org/0000-0002-5154-1929
Pruteanu, Lavinia-Lorena https://orcid.org/0000-0001-8277-1113
Jacobson, Rachel DeVay https://orcid.org/0009-0004-2443-0600
Handa, Koichi https://orcid.org/0000-0003-2748-9742
Hirano, Mariko https://orcid.org/0009-0007-9574-7551
Seal, Srijit https://orcid.org/0000-0003-2790-8679
Mahale, Manas https://orcid.org/0009-0007-3867-996X
Schmidt, Marco F.
Ahfeldt, Tim https://orcid.org/0000-0001-6377-7376
Grisoni, Francesca https://orcid.org/0000-0001-8552-6615
Cortes-Ciriano, Isidro
- License Information
-
More Information
Article History
Accepted: 20 June 2026
First Online: 7 August 2026
Ethics
Competing interests: A.B. is a shareholder or options holder of or consultant with Healx, Pharmenable Therapeutics, Pangea Bio, Cresset Group, Evolvus, Harmonic Discovery, Ignota Labs, Turbine, VALID, Daimedex, EtioMap, Apheris, AstraZeneca and Novartis. M.C.T. has no competing interests to declare. J.W.S. is director and shareholder of JW Scannell Analytics, director and shareholder of Etheros Pharmaceuticals, holds equity options in Ochro Bio and has an advisory role with Hiro Capital. D.A.S. has no competing interests to declare. G.M.G. is a shareholder in AstraZeneca, Vertex and Nvidia. J.G.G. has no competing interests to declare. L.-L.P. has no competing Interests to declare. R.D.J. is CSO and cofounder of Powerhouse Biology and owns shares in the company. K.H. is an employee of Meiji Seika Pharma Co. and is a shareholder of Teijin Pharma. M.H. is an employee of Tanabe Pharma Corporation. S.S. is an employee of Human Chemical Company. M.M. has no competing interests to declare. M.F.S. is an employee and shareholder of biotx.ai. T.A. is CEO and cofounder of VALID and owns shares in the company. F.G. has no competing interests to declare. I.C.-C. has no competing interests to declare.
